U.S. markets closed

Arena Pharmaceuticals, Inc. (ARNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
63.82+2.50 (+4.08%)
At close: 4:00PM EDT
63.82 0.00 (0.00%)
After hours: 05:59PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/28/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.53
52-Week Change 30.92%
S&P500 52-Week Change 335.08%
52 Week High 390.19
52 Week Low 359.55
50-Day Moving Average 366.54
200-Day Moving Average 370.15

Share Statistics

Avg Vol (3 month) 3388.29k
Avg Vol (10 day) 3256.46k
Shares Outstanding 560.7M
Implied Shares Outstanding 6N/A
Float 56.5M
% Held by Insiders 10.27%
% Held by Institutions 195.16%
Shares Short (Jul 14, 2021) 42.94M
Short Ratio (Jul 14, 2021) 47.4
Short % of Float (Jul 14, 2021) 45.42%
Short % of Shares Outstanding (Jul 14, 2021) 44.85%
Shares Short (prior month Jun 14, 2021) 43.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 18, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jun 18, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-796,349.12%

Management Effectiveness

Return on Assets (ttm)-24.96%
Return on Equity (ttm)-40.78%

Income Statement

Revenue (ttm)57k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-323.42M
EBITDA -450.04M
Net Income Avi to Common (ttm)-422.94M
Diluted EPS (ttm)-7.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.09B
Total Cash Per Share (mrq)17.94
Total Debt (mrq)54.99M
Total Debt/Equity (mrq)5.06
Current Ratio (mrq)23.61
Book Value Per Share (mrq)17.92

Cash Flow Statement

Operating Cash Flow (ttm)-379.04M
Levered Free Cash Flow (ttm)-221.36M